BEDMINSTER, N.J. and DUBLIN, Ireland, July 31, 2012 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today that it will host a conference call with members of Amarin senior management to discuss the company’s second quarter 2012 financial results and provide a business overview on Wednesday, August 8, 2012, at 4:30 p.m. EDT. The conference call will follow the anticipated release of Amarin’s second quarter 2012 financial results earlier that day.
